Quantoom Biosciences

Gosselies, BE
Platform Provider
mRNA
Program data pending ClinicalTrials.gov matching · Last scored 2026-03-15
56.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (1)

Quick Facts: Quantoom Biosciences

Signal Score
56.5/100 (as of 2026-03-15)
Quality Compliance
Assessment pending
Headquarters
Gosselies, BE
Modalities
mRNA
Active CGT Programs
No ClinicalTrials.gov matches confirmed — 1 partnership announcement in press
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CGT manufacturing intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 1 partnership announcement found in press monitoring.
Programs — no verified data
Sponsors— no verified data
ModalitiesmRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 53.0
1 CGT manufacturing site: Gosselies, BE
Modalities: mRNA
Capacity assessment: 55.0/100
Sites: Gosselies, BE
Source: SEC EDGAR, press monitoring, company profiles
1 CGT manufacturing site
Recent Press1 articles
1 CGT manufacturing site: Gosselies, BE
Modalities: mRNA
Capacity assessment: 55.0/100

Recent News 1 articles

partnership 2026-02-24
Cellipont Bioservices and Soter Bio Announce Strategic Collaboration to Support Integrated U.S. Cell Therapy Manufacturing - BioSpace
Cellipont Bioservices and Soter Bio Announce Strategic Collaboration to Support Integrated U.S. Cell Therapy Manufacturing  BioSpace
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
mRNA CDMOs →